logo
episode-header-image
Aug 2022
49m 42s

#349 Hotcakes: Tirzepatide for weight lo...

The Curbsiders Internal Medicine Podcast
About this episode
tail spinning
Up next
Jul 27
#534: Supplements in Primary Care
Separating Signal from HypePatients bring us lists. Greens powders, magnesium for everything, vitamin D “for immunity,” fish oil, creatine, curcumin… so how do we separate signals from hype without becoming the office that just says “no” to everything? In this home-grown deep div ... Show More
1h 24m
Jul 20
#533: What’s the Tea on Kratom?
Caring for patients using mitragynine-derived substancesFamiliarize yourself with the differences in mitragynine-derived compounds. Understand how to identify and manage kratom use disorder and withdrawal from mitragynine-derived compounds. We’re joined by Dr. Jonathan Tanawan (P ... Show More
1h 5m
Jul 13
#532: Updates in Fibromyalgia Management featuring Dr. Dan Clauw
From Pain to Gain: Diagnosis to Updated Treatment OptionsLearn how to recognize fibromyalgia as a disorder of central pain processing, distinguish it from common mimics, and apply evidence-based strategies for diagnosis and management. In this episode, Dr. Daniel Clauw (Universit ... Show More
1h 25m
Recommended Episodes
Aug 2023
Obesity Rx: How to Use New Medications in Clinic
Drs Robert Kushner and obesity pharmacotherapy expert Ania Jastreboff discuss how to use the new obesity medications effectively in clinic. Tune in to hear expert recommendations on patient communication, side effects, and more. Relevant disclosures can be found with the episode ... Show More
21m 49s
Jul 2024
Obesity Medications
<p>New weight-loss drugs have transformed care for people with obesity. In this Clinical Reviews podcast, Robert F. Kushner, MD, MS, of Northwestern University Feinberg School of Medicine joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss prescribing these drugs to im ... Show More
17m 54s
Oct 2023
#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial
What is the difference between semaglutide (ozempic) and tirzepatide (mounjaro) in outcomes and mechanism? How did we find out diabetes medications can help with weight loss?Sponsors: Post Investment: Real Estate Syndications || Hellofresh Show Notes & Transcript02:08 Framework f ... Show More
21m 59s
Apr 2022
Apr 29, 2022 This Week in Cardiology Podcast
<p>Aspirin for primary prevention, time-restricted feeding, renal denervation, and a potential new obesity drug are the topics John Mandrola, MD, covers in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only.</em> <u>To read a partial transc ... Show More
21m 33s
Jul 2025
122 | How to Support Patients on Obesity Medications: A Short Course on Side Effects, Satiety & Supplements
<p><a href='https://www.examroomnutrition.com/course'>Join The Obesity Medicine Nutrition Course</a>! Enter code POD15 at checkout for 15% off!</p><p>Anti-obesity medications are everywhere—but they also come with new challenges. From rapid weight loss and side effects to TikTok- ... Show More
29m 21s
May 2024
Tirzepatide: Weighing the Options
Mickenzie Meyers, PharmD shares insights on pharmacotherapeutic approaches to weight loss. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at ... Show More
29m 46s
Mar 2023
Weight Loss Meds: Is Ozempic a Miracle Drug?
People say drugs like Ozempic are helping them lose tons of weight. But are these drugs really all they’re cracked up to be? Or could this be yet another dangerous weight loss fad? We talk to endocrinologists Prof. Tricia Tan and Dr. Daniela Hurtado. Note: In this episode we disc ... Show More
38m 25s
Dec 2024
Dec 06 2024 This Week in Cardiology
<p>Tirzepatide vs semaglutide in obesity; GLP1a use is complicated; HF outcomes; the misuse of meta-analyses in HF; and a breakthrough in HF care are the topics John Mandrola, MD, covers this week.</p> <p><strong><em>This podcast is intended for healthcare professionals only</em> ... Show More
27m 37s
May 2024
May 17 2024 This Week in Cardiology
<p>An Impella update, another TAVI vs SAVR trial, two studies on angina and PCI, another null substudy from REVIVED-BCIS, and semaglutide are the topics John Mandrola, MD, covers in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>.</ ... Show More
29m 51s